维普中文期刊产品整合服务
59篇 您的检索式:作者名="PESKIND ER"
    题名 作者 年代 出处 被引量
1Memantine treatment in mild to moderate Alzheimer disease:a 24-week randomized,controlled trial显示文摘Peskind ER Potkin SG Pomara N 0,,08:1
2Increased risk of dementia in mothers of Alzheimer's disease cases:evidence for maternal inheritance显示文摘Edland SD Silverman JM Peskind ER 1996Neurology1996,47,:1
3Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration显示文摘 Peskind ER Digiacomo L 1997Am J Psychiatry1997,154,1:1
4Insulin increases CSF Aβ42levels in normal older adults显示文摘Watson GS Peskind ER Asthana S 2003Neurology2003,60,:1
5Memantine treatment in mild to moderate alzheimer disease : a 24-week random- ized, controlled trial 显示文摘Peskind ER Singh B Cree A 2006Am J Geriatr Psychiatry2006,14,8:1
6Patterns of cerebrospinal fluid cathchols support increased central noradenergic responsiveness in aging and Alzheimer's disease显示文摘 Peskind ER Holmes C 1999Biol Psychiatry1999,15,46:1
7The cognitive benefits of galantamine are sustained for at least 36 months:a long-term extension trim显示文摘RASKIND MA PESKIND ER TRUYEN L 2004Arch Neurol2004,61,2:1
8Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease显示文摘Peskind ER Griffin WS Akama KT 2001Neurochem Int2001,39,56:1
9Memamine treatment in mild to moderate Alzheimer disease: a 24-week ran domized, comrolled trial显示文摘Peskind ER Potkin SG Pomara N 2006Am J Geriatr Psychiatry2006,14,8:1
10Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease显示文摘Peskind ER Griffin WS Akama KT 2001Neurochem Int2001,39,56:1
11Insulin increases CSF Aβ42 levels in normal older adults显示文摘Watson GS Peskind ER Asthana S 2003Neurology2003,60,:1
12Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer' s disease显示文摘Peskind ER Griffin WS Akama KT 2001Neurochem Int2001,39,56:1
13Memantine treatment in mild to moderate Alzheimer disease:a 24-week randomized,controlled trial显示文摘Peskind ER Potkin SG Pomara N 2006Am J Geriatr Psychiatry2006,14,8:1
14Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension显示文摘Raskind MA Peskind ER Wessel T 2000Neurology2000,54,12:1
15Influence of lifestyle modifica- tions on age-related free radical injury to brain显示文摘Peskind ER Li G Shofer JB 2014JAMA Neurol2014,71,9:1
16Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder显示文摘 Tsuang D Peskind ER 2001Psychiatry Res2001,102,3:1
17Changes in the sleep and waking EEGs of non-demented and demented elderly subjects显示文摘Prinz PN Peskind ER Vitaliano PP 1982J Am Geriatr Soc1982,30,:1
18Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized,controlled trial 显示文摘Peskind ER Potkin SG Pomara N 2006Am J Geriatr Psychiatry2006,14,8:1
19Cerebrocerebellar hypo- metabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms显示文摘Peskind ER Petrie EC Cross D J 2011Neuroimage2011,541,:1
20The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial显示文摘Raskind MA Peskind ER Truyen L 2004Arch Nenrol2004,61,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费